The Lancet Haematology launched in Autumn 2014, joining the growing collection of Lancet specialty journals. As an exclusively online journal, this new monthly title is dedicated to publishing original research that advocates change in, or illuminates, haematological clinical practice.
…
continue reading
Lan-Lan Smith, Editor-in-Chief, and Emma Cookson, Senior Editor at The Lancet Haematology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy. A monthly audio companion to the journal, this podcast covers a broad range of topics, from racial and ethnic disparities in leukaemia survival outcomes to resuscitation with blood products compared with saline, the link between mental health and lymphoma to haemol ...
…
continue reading
Professor Banu Aygun joins us to discuss the REACH trial testing hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00078-4?dgcid=buzzsprout_icw_podcast_generic_lanhae Continue this conversation on social! Follow us toda…
…
continue reading
1
In conversation with... Banu Aygun
11:13
11:13
Afspil senere
Afspil senere
Lister
Like
Liked
11:13
Professor Banu Aygun joins us to discuss the REACH trial testing hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa.Af The Lancet
…
continue reading
1
In conversation with... Sabine Braat and Katherine Fielding
18:06
18:06
Afspil senere
Afspil senere
Lister
Like
Liked
18:06
Dr Sabine Braat and Dr Katherine Fielding join us to discuss their study presenting new haemoglobin thresholds for defining anaemia.Af The Lancet
…
continue reading
1
Sabine Braat and Katherine Fielding on haemoglobin thresholds to define anaemia
18:06
18:06
Afspil senere
Afspil senere
Lister
Like
Liked
18:06
Dr Sabine Braat and Dr Katherine Fielding join us to discuss their study presenting new haemoglobin thresholds for defining anaemia. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00030-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhae Continue this conversation on social! Follow us today at... https:…
…
continue reading
1
Elisabeth Schorb on the MARTA phase 2 trial
9:23
9:23
Afspil senere
Afspil senere
Lister
Like
Liked
9:23
Doctor Elisabeth Schorb joins us to discuss the MARTA phase 2 trial, treating older, fit patients with primary diffuse large B-cell CNS lymphoma with high-dose chemotherapy and autologous stem-cell transplantation. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00371-X/fulltext?dgcid=buzzsprout_icw_podcast…
…
continue reading
1
In conversation with... Elisabeth Schorb
9:23
9:23
Afspil senere
Afspil senere
Lister
Like
Liked
9:23
Doctor Elisabeth Schorb joins us to discuss the MARTA phase 2 trial, treating older, fit patients with primary diffuse large B-cell CNS lymphoma with high-dose chemotherapy and autologous stem-cell transplantation.Af The Lancet
…
continue reading
1
In conversation with... Stephan Ehl
13:03
13:03
Afspil senere
Afspil senere
Lister
Like
Liked
13:03
Professor Stephan Ehl joins us to discuss a prospective observational study on paediatric autoimmune lymphoproliferative immunodeficiencies.Af The Lancet
…
continue reading
1
Stephan Ehl on paediatric autoimmune lymphoproliferative immunodeficiencies
13:03
13:03
Afspil senere
Afspil senere
Lister
Like
Liked
13:03
Professor Stephan Ehl joins us to discuss a prospective observational study on paediatric autoimmune lymphoproliferative immunodeficiencies. Read the full article: https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00638-1/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanonc Continue this conversation on social! Follow us today at..…
…
continue reading
1
In conversation with... Sarah O'Brien
13:50
13:50
Afspil senere
Afspil senere
Lister
Like
Liked
13:50
Dr Sarah O'Brien joins Lan-Lan Smith to discuss results of the phase 3 PREVAPIX-ALL trial, which compares direct oral anticoagulant apixaban to low-molecular-weight-heparin for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma.Af The Lancet
…
continue reading
1
Dr Sarah O'Brien on the PREVAPIX-ALL trial
13:50
13:50
Afspil senere
Afspil senere
Lister
Like
Liked
13:50
Dr Sarah O'Brien joins Lan-Lan Smith to discuss results of the phase 3 PREVAPIX-ALL trial, which compares direct oral anticoagulant apixaban to low-molecular-weight-heparin for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma. Read the full article: https://www.thelancet.com/journal…
…
continue reading
1
In conversation with... Enrico Lopriore
12:33
12:33
Afspil senere
Afspil senere
Lister
Like
Liked
12:33
Professor Enrico Lopriore joins us to discuss a trial testing darbepoetin alfa to prevent postnatal anaemia in infants with haemolytic disease of the fetus and newborn.Af The Lancet
…
continue reading
1
Enrico Lopriore on haemolytic disease of the fetus and newborn
12:33
12:33
Afspil senere
Afspil senere
Lister
Like
Liked
12:33
Professor Enrico Lopriore joins us to discuss a trial testing darbepoetin alfa to prevent postnatal anaemia in infants with haemolytic disease of the fetus and newborn. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00285-5/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhae Continue this conversation on …
…
continue reading
Professor Meletios Dimopoulos joins us to discuss two trials for patients with relapsed and refractory multiple myeloma - the first report of the DREAMM-3 phase 3 and long-term follow-up of the APOLLO phase 3 trial.Af The Lancet
…
continue reading
1
Meletios Dimopoulos on relapsed and refractory multiple myeloma
11:00
11:00
Afspil senere
Afspil senere
Lister
Like
Liked
11:00
Professor Meletios Dimopoulos joins us to discuss two trials for patients with relapsed and refractory multiple myeloma - the first report of the DREAMM-3 phase 3 and long-term follow-up of the APOLLO phase 3 trial. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00243-0/fulltext?dgcid=buzzsprout_icw_podcas…
…
continue reading
1
In conversation with... Eric Ohuma
16:27
16:27
Afspil senere
Afspil senere
Lister
Like
Liked
16:27
Dr Eric Ohuma joins us to tell us about a study recently published in The Lancet Haematology on the association between maternal haemoglobin concentrations and maternal and neonatal outcomes.Af The Lancet
…
continue reading
1
Eric Ohuma on haemoglobin concentrations and neonatal outcomes
16:27
16:27
Afspil senere
Afspil senere
Lister
Like
Liked
16:27
Dr Eric Ohuma joins us to tell us about a study recently published in The Lancet Haematology on the association between maternal haemoglobin concentrations and maternal and neonatal outcomes. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00170-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhae Continu…
…
continue reading
1
In conversation with... Margaret Ragni
13:13
13:13
Afspil senere
Afspil senere
Lister
Like
Liked
13:13
Professor Margaret Ragni joins us to discuss the VWDMin study, published in The Lancet Haematology. In this phase 3, randomised, crossover trial, recombinant von Willebrand factor and tranexamic acid are used to treat heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA.…
…
continue reading
1
Margaret Ragni on tranexamic acid to treat heavy menstrual bleeding
13:13
13:13
Afspil senere
Afspil senere
Lister
Like
Liked
13:13
Professor Margaret Ragni joins us to discuss the VWDMin study, published in The Lancet Haematology. In this phase 3, randomised, crossover trial, recombinant von Willebrand factor and tranexamic acid are used to treat heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA. Read the full article: https://www.th…
…
continue reading
1
In conversation with... Oreofe Odejide and Thomas Kuczmarski
16:32
16:32
Afspil senere
Afspil senere
Lister
Like
Liked
16:32
Dr Odejide and Dr Kuczmarski tell us about a study recently published in The Lancet Haematology on the effect of pre-existing mental health conditions on survival in patients with diffuse large B-cell lymphoma.Af The Lancet
…
continue reading
1
Oreofe Odejide and Thomas Kuczmarski on mental health and lymphoma
16:32
16:32
Afspil senere
Afspil senere
Lister
Like
Liked
16:32
Dr Odejide and Dr Kuczmarski tell us about a study recently published in The Lancet Haematology on the effect of pre-existing mental health conditions on survival in patients with diffuse large B-cell lymphoma. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00094-7/fulltext?dgcid=buzzsprout_icw_podcast_gen…
…
continue reading
1
In conversation with... Alok Srivastava
18:41
18:41
Afspil senere
Afspil senere
Lister
Like
Liked
18:41
Professor Alok Srivastava tells us about two clinical trials being published in The Lancet and The Lancet Haematology on a new siRNA therapy called fitusiran for patients with haemophilia A and B.Af The Lancet
…
continue reading
1
Alok Srivastava on fitusiran for patients with haemophilia A and B
18:41
18:41
Afspil senere
Afspil senere
Lister
Like
Liked
18:41
Professor Alok Srivastava tells us about two clinical trials being published in The Lancet and The Lancet Haematology on a new siRNA therapy called fitusiran for patients with haemophilia A and B. Read the two trials: Efficacy and safety of fitusiran prophylaxis in people with haemophilia A or haemophilia B with inhibitors (ATLAS-INH) https://www.t…
…
continue reading
1
Emmanuela E Ambrose on stroke prevention in children with sickle cell disease
11:31
11:31
Afspil senere
Afspil senere
Lister
Like
Liked
11:31
Dr Emmanuela E Ambrose tells us about the SPHERE trial on hydroxyurea dose escalation for primary stroke prevention in children with sickle cell disease in Tanzania Read the full article: Hydroxyurea with dose escalation for primary stroke risk reduction in children with sickle cell anaemia in Tanzania (SPHERE) Continue this conversation on social!…
…
continue reading
1
In conversation with... Emmanuela E Ambrose
11:31
11:31
Afspil senere
Afspil senere
Lister
Like
Liked
11:31
Dr Emmanuela E Ambrose tells us about the SPHERE trial on hydroxyurea dose escalation for primary stroke prevention in children with sickle cell disease in TanzaniaAf The Lancet
…
continue reading
1
Sumit Gupta on racial and ethnic disparities in leukaemia survival outcomes
22:10
22:10
Afspil senere
Afspil senere
Lister
Like
Liked
22:10
Dr Sumit Gupta discusses how racial and ethnic disparities affect survival outcomes of children and young adults with acute lymphocytic leukaemia. Read the full article: Racial and ethnic disparities in childhood and young adult acute lymphocytic leukaemia Continue this conversation on social! Follow us today at... https://twitter.com/thelancet htt…
…
continue reading
1
In conversation with... Sumit Gupta
22:10
22:10
Afspil senere
Afspil senere
Lister
Like
Liked
22:10
Dr Sumit Gupta discusses how racial and ethnic disparities affect survival outcomes of children and young adults with acute lymphocytic leukaemia.Af The Lancet
…
continue reading
1
In conversation with... Xiao-Jun Huang
28:10
28:10
Afspil senere
Afspil senere
Lister
Like
Liked
28:10
Professor Xiao-Jun Huang discusses this Lancet Haematology series on Cellular Therapy in China, covering the history, current research challenges, and future of HSCT and CAR T-cell therapies in China.Af The Lancet
…
continue reading
1
Xiao-Jun Huang on cellular therapy in China
28:10
28:10
Afspil senere
Afspil senere
Lister
Like
Liked
28:10
Professor Xiao-Jun Huang discusses this Lancet Haematology series on Cellular Therapy in China, covering the history, current research challenges, and future of HSCT and CAR T-cell therapies in China. Read the Series papers: Cellular therapy in China Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://i…
…
continue reading
1
Glenn Pierce on haemophilia care in LMICs
34:55
34:55
Afspil senere
Afspil senere
Lister
Like
Liked
34:55
Dr Glenn Pierce discusses the World Federation of Hemophilia’s Humanitarian Aid Program which provides access to haemophilia care in low-income and lower-middle-income countries. Read the full Review: Achieving access to haemophilia care in low-income and lower-middle-income countries Continue this conversation on social! Follow us today at... http…
…
continue reading
1
In conversation with... Glenn Pierce
34:55
34:55
Afspil senere
Afspil senere
Lister
Like
Liked
34:55
Dr Glenn Pierce discusses the World Federation of Hemophilia’s Humanitarian Aid Program which provides access to haemophilia care in low-income and lower-middle-income countries.Af The Lancet
…
continue reading
1
Amy DeZern on the link between myelodysplastic syndrome and autoimmune disorders
12:50
12:50
Afspil senere
Afspil senere
Lister
Like
Liked
12:50
Dr Amy DeZern discusses the link between myelodysplastic syndrome and autoimmune disorders and the need for a multidisciplinary approach for the treatment of patients who have both. Read the full article: Myelodysplastic syndrome and autoimmune disorders: two sides of the same coin? Continue this conversation on social! Follow us today at... https:…
…
continue reading
1
In conversation with... Amy DeZern
12:50
12:50
Afspil senere
Afspil senere
Lister
Like
Liked
12:50
Dr Amy DeZern discusses the link between myelodysplastic syndrome and autoimmune disorders and the need for a multidisciplinary approach for the treatment of patients who have both.Af The Lancet
…
continue reading
1
In conversation with... Nicholas Crombie and Gavin Perkins
15:05
15:05
Afspil senere
Afspil senere
Lister
Like
Liked
15:05
Dr Nicholas Crombie and Professor Gavin Perkins discuss their randomised phase 3 trial in which they investigated resuscitation with blood products compared with saline in patients with trauma-related haemorrhagic shock receiving prehospital care.Af The Lancet
…
continue reading
1
Nicholas Crombie and Gavin Perkins on resuscitation with blood products compared with saline
15:05
15:05
Afspil senere
Afspil senere
Lister
Like
Liked
15:05
Dr Nicholas Crombie and Professor Gavin Perkins discuss their randomised phase 3 trial in which they investigated resuscitation with blood products compared with saline in patients with trauma-related haemorrhagic shock receiving prehospital care. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://inst…
…
continue reading
1
In conversation with... Fredrik Schjesvold
12:24
12:24
Afspil senere
Afspil senere
Lister
Like
Liked
12:24
Dr Fredrik Schjesvold discusses the results of the OCEAN phase 3 trial testing melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide.Af The Lancet
…
continue reading
1
Fredrik Schjesvold on OCEAN phase 3
12:24
12:24
Afspil senere
Afspil senere
Lister
Like
Liked
12:24
Dr Fredrik Schjesvold discusses the results of the OCEAN phase 3 trial testing melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide. Read the full article: Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN) Continue this conversatio…
…
continue reading
1
Jacob D Soumerai and Andrew D Zelenetz on the BOVen regimen for previously untreated patients with chronic lymphocytic leukaemia
11:59
11:59
Afspil senere
Afspil senere
Lister
Like
Liked
11:59
Dr Jacob D Soumerai and Prof Andrew D Zelenetz discuss their phase 2 trial of the BOVen regimen and MRD-driven treatment discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(21)00307-0/fulltext Continu…
…
continue reading
1
In conversation with... Jacob D Soumerai and Andrew D Zelenetz
11:59
11:59
Afspil senere
Afspil senere
Lister
Like
Liked
11:59
Dr Jacob D Soumerai and Prof Andrew D Zelenetz discuss their phase 2 trial of the BOVen regimen and MRD-driven treatment discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma.Af The Lancet
…
continue reading
1
Raul Cordoba on haematological malignancies in older people
16:24
16:24
Afspil senere
Afspil senere
Lister
Like
Liked
16:24
Dr Raul Cordoba discusses the joint Series between The Lancet Healthy Longevity and The Lancet Haematology on haematological malignancies in older people. Read the full article: A comprehensive approach to therapy of haematological malignancies in older patients Continue this conversation on social! Follow us today at... https://twitter.com/thelanc…
…
continue reading
1
In conversation with... Raul Cordoba
16:24
16:24
Afspil senere
Afspil senere
Lister
Like
Liked
16:24
Dr Raul Cordoba discusses the joint Series between The Lancet Healthy Longevity and The Lancet Haematology on haematological malignancies in older people.Af The Lancet
…
continue reading
1
In conversation with…Obiageli Nnodu and Dennis Chao
9:03
9:03
Afspil senere
Afspil senere
Lister
Like
Liked
9:03
Professor Obiageli Nnodu and Dr Dennis Chao join acting Deputy Editor Emma Cookson to talk about their new study describing modelling of child mortality as a result of sickle cell disease in Nigeria.Af The Lancet
…
continue reading
1
Obiageli Nnodu and Dennis Chao on child mortality from sickle cell disease in Nigeria
9:03
9:03
Afspil senere
Afspil senere
Lister
Like
Liked
9:03
Professor Obiageli Nnodu and Dr Dennis Chao join acting Deputy Editor Emma Cookson to talk about their new study describing modelling of child mortality as a result of sickle cell disease in Nigeria. Read the full article: https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(21)00191-5/fulltext Continue this conversation on social! Follo…
…
continue reading
1
In conversation with... Dr Zuguo Mei and Dr Gary M Brittenham
8:34
8:34
Afspil senere
Afspil senere
Lister
Like
Liked
8:34
Dr Zuguo Mei and Dr Gary M Brittenham talk about their work defining physiologically based serum ferritin thresholds for iron deficiency.Af The Lancet
…
continue reading
1
Zuguo Mei and Gary Brittenham on iron deficiency
8:34
8:34
Afspil senere
Afspil senere
Lister
Like
Liked
8:34
Senior Assistant Editor Ben Burwood speaks with Dr Zuguo Mei (Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA) and Dr Gary M Brittenham (Department of Pediatrics, College of Physicians and Surgeons, Columbia Unive…
…
continue reading
1
Eugenia Trigoso Arjona (in Spanish) on nursing and haematological care
29:11
29:11
Afspil senere
Afspil senere
Lister
Like
Liked
29:11
Para el Día International de la Enfermera, Eugenia Trigoso Arjona, enfermera coordinadora en el Hospital La Fe (Valencia, España) y presidenta del comité de educación de la European Society for Blood and Marrow Transplantation Nurses hablo con la Editora Yaiza del Pozo Martin sobre como las enfermeras pueden remodelar el futuro de la hematología. C…
…
continue reading
1
Eugenia Trigoso Arjona (in English) on nursing and haematological care
28:34
28:34
Afspil senere
Afspil senere
Lister
Like
Liked
28:34
To mark International Nurses Day, Eugenia Trigoso Arjona, nurse coordinator at Hospital La Fe (Valencia, Spain) and chair of the European Society for Blood and Marrow Transplantation Nurses Global Education Committee, joins acting Editor-in-Chief Yaiza del Pozo Martin to discuss how nurses can reshape the future of haematological care. Continue thi…
…
continue reading
Para el Día International de la Enfermera, Eugenia Trigoso Arjona, enfermera coordinadora en el Hospital La Fe (Valencia, España) y presidenta del comité de educación de la European Society for Blood and Marrow Transplantation Nurses hablo con la Editora Yaiza del Pozo Martin sobre como las enfermeras pueden remodelar el futuro de la hematología.…
…
continue reading
1
In conversation with... Eugenia Trigoso Arjona (in English)
28:34
28:34
Afspil senere
Afspil senere
Lister
Like
Liked
28:34
To mark International Nurses Day, Eugenia Trigoso Arjona, nurse coordinator at Hospital La Fe (Valencia, Spain) and chair of the European Society for Blood and Marrow Transplantation Nurses Global Education Committee, joins acting Editor-in-Chief Yaiza del Pozo Martin to discuss how nurses can reshape the future of haematological care.…
…
continue reading
1
Nada Hamad on inclusion and diversity in haematology
30:02
30:02
Afspil senere
Afspil senere
Lister
Like
Liked
30:02
A/Prof Nada Hamad (St Vincent’s hospital, Sydney, Australia) joins Editor-in-Chief Dr Lan-Lan Smith to discuss inclusion and diversity in haematology-oncology and transplantation. Continue this conversation on social! Follow us today at... https://twitter.com/thelancet https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljourna…
…
continue reading
A/Prof Nada Hamad (St Vincent’s hospital, Sydney, Australia) joins Editor-in-Chief Dr Lan-Lan Smith to discuss inclusion and diversity in haematology-oncology and transplantation.Af The Lancet
…
continue reading